SCHEMBL612164

SCHEMBL612164

CC(O)CC(=O)OC1CCCC(C)(C(C)C)C1

nearest known ligand 0.38

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.38
NAAA Q02083 2/20 0.32
HTT P42858 1/20 0.31
MEN1 O00255 1/20 0.30
LMNA P02545 1/20 0.30
KMT2A Q03164 1/20 0.30
CYP19A1 P11511 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16457292 1.00 CYP2C19 (0.38) CYP2C19NAAAHTTMEN1LMNA
SCHEMBL28012006 1.00 CYP2C19 (0.38) CYP2C19NAAAHTTMEN1LMNA
SCHEMBL4630115 0.86 CACNA1B (0.30)
SCHEMBL613730 0.86 NAAA (0.36) CYP2C19NAAA
SCHEMBL11408977 0.84 CYP2C19 (0.36) CYP2C19NAAAHTT
SCHEMBL698620 0.83 CYP2C19 (0.35) CYP2C19NAAAHTT
SCHEMBL18825657 0.82 NAAA (0.37) CYP2C19NAAALMNA
SCHEMBL4063062 0.82 EPHX1 (0.32) CYP2C19
SCHEMBL614025 0.81 CYP19A1 (0.33) CYP2C19CYP19A1
SCHEMBL118102 0.80 CYP3A4 (0.35) CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 463 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210212983-A1 ORAL CANNABINOID DELIVERY FORMULATIONS WITH MOUTHFEEL EXPERIENCE ENHANCERS CHICAGO ATLANTIC ADMIN, LLC 2021-07-15 US claimed
CN-112638355-A Cosmetic and cleaning product 株式会社资生堂 2021-04-09 CN claimed
WO-2020044956-A1 COSMETIC AND CLEANSER 株式会社 資生堂 2020-03-05 WO claimed
US-10392371-B2 Compounds useful as modulators of TRPM8 SENOMYX, INC. (US) 2019-08-27 US claimed
EP-1924148-B1 CONFECTIONERY COMPOSITION INCLUDING AN ELASTOMERIC COMPONENT, A COOKED SACCHARIDE COMPONENT, AND A SENSATE INTERCONTINENTAL GREAT BRANDS LLC (US) 2016-07-20 EP claimed
US-20160128944-A1 COATED PARTICLES AND COMPOSITIONS COMPRISING SAME VYOME THERAPEUTICS LIMITED (IN) 2016-05-12 US claimed
US-9320705-B2 Sensation modifying topical composition foam FOAMIX PHARMACEUTICALS LTD. (IL) 2016-04-26 US claimed
EP-3003031-A1 COATED PARTICLES AND COMPOSITIONS COMPRISING SAME Vyome Biosciences Pvt Ltd (IN) 2016-04-13 EP claimed
WO-2014195872-A1 COATED PARTICLES AND COMPOSITIONS COMPRISING SAME VYOME BIOSCIENCES PVT. LTD. (IN) 2014-12-11 WO claimed
US-20120237453-A1 SENSATION MODIFYING TOPICAL COMPOSITION FOAM FOAMIX LTD. (IL) 2012-09-20 US claimed
US-20100129489-A1 SENSATE-PLATED SANDING COMPOSITION AND PRODUCTS MADE THEREFROM INTERCONTINENTAL GREAT BRANDS LLC 2010-05-27 US claimed
US-20080253973-A1 SENSATION MODIFYING TOPICAL COMPOSITION FOAM FOAMIX LTD. (IL) 2008-10-16 US claimed
US-20070148103-A1 Compositions providing a heating sensation for oral or dermal delivery CADBURY ADAMS USA, LLC. 2007-06-28 US claimed
WO-1999039683-A1 ANTI-DANDRUFF SHAMPOO COMPOSITION COMPRISING A COOL-FEELING AGENT THE PROCTER & GAMBLE COMPANY (US) 1999-08-12 WO claimed
JP-10313819-A None JP disclosed
EP-3869971-B1 CENTER-FILLED CONFECTIONERY PRODUCT; COATED PRODUCT; AND METHODS OF MAKING INTERCONTINENTAL GREAT BRANDS LLC (US) 2024-07-10 EP disclosed
EP-4380553-A1 STABILISED COMPOSITIONS Rumin8 Pty Ltd (AU) 2024-06-12 EP disclosed
WO-1999039683-A1 ANTI-DANDRUFF SHAMPOO COMPOSITION COMPRISING A COOL-FEELING AGENT THE PROCTER & GAMBLE COMPANY (US) 1999-08-12 WO disclosed
WO-1999039683-A1 ANTI-DANDRUFF SHAMPOO COMPOSITION COMPRISING A COOL-FEELING AGENT THE PROCTER & GAMBLE COMPANY (US) 1999-08-12 WO disclosed
JP-H10313819-A SWEET FOOD SANEI GEN F F I INC 1998-12-02 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070148103-A1 Compositions providing a heating sensation for oral or dermal delivery TAS2R8, TAS2R60, TAS2R20 CYP2C19 1261/4885NAAA 1248/4885HTT 1150/4885
US-10392371-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM4, TRPM6 CYP2C19 4193/4885NAAA 1253/4885HTT 3860/4885
US-20080253973-A1 SENSATION MODIFYING TOPICAL COMPOSITION FOAM TRPA1, GPR35, TRPV1 CYP2C19 1460/4885NAAA 1587/4885HTT 3078/4885
US-20120237453-A1 SENSATION MODIFYING TOPICAL COMPOSITION FOAM TRPA1, GPR35, TRPV1 CYP2C19 1460/4885NAAA 1587/4885HTT 3078/4885
US-20210212983-A1 ORAL CANNABINOID DELIVERY FORMULATIONS WITH MOUTHFEEL EXPERIENCE ENHANCERS CNR2, CNR1, CPNE4 CYP2C19 477/4885NAAA 2025/4885HTT 2929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.